Leaders Insights
Leaders Insights

Stay at the top of your field, a little every day.

DomainsMarketingDataFinanceAI
ResourcesLearnTestToolsBlogGlossary
© 2026 Leaders Insights — All rights reserved.
Tracks/Marketing in FMCG/Regulation, compliance and checks/Why FMCG advertising claims get pulled after launch, not before
1/4+150 XP

Regulation, compliance and checks

10Why FMCG advertising claims get pulled after launch, not before+15011Marketing to kids without losing the aisle they walk down+15012Green claims, greenwashing fines and the recyclability label trap+15013The pre-launch compliance gauntlet: from pack copy to shelf-ready+150

Why FMCG advertising claims get pulled after launch, not before

# Why FMCG advertising claims get pulled after launch, not before

In 2007, Kellogg's had to pull "helps support your child's immunity" claims from Rice Krispies boxes after the US Federal Trade Commission (FTC) found the substantiation didn't hold up. The boxes had already been on shelves for months. This is the pattern in FMCG (fast-moving consumer goods, meaning packaged products like food, drinks, cosmetics and household goods sold in high volumes): claims launch first, get challenged second, and pulled third. Almost never the reverse.

Why does an industry with entire legal departments keep shipping claims that don't survive contact with regulators or competitors? The answer is structural, not sloppy. Understanding it is core to marketing fluency in this sector.

The pre-clearance myth

Unlike pharmaceuticals, most FMCG advertising claims are not pre-approved by a regulator before launch. There is no FDA (US Food and Drug Administration) sign-off queue for "70% more moisturizing" on a lotion bottle.

Instead, the system runs on ex-post enforcement: brands self-certify that claims are substantiated, then regulators, competitors or watchdogs challenge them after the fact. In the US, the FTC enforces under the FTC Act's Section 5 (banning "unfair or deceptive acts or practices"). In the EU, the relevant framework is the Unfair Commercial Practices Directive (2005/29/EC), enforced by national consumer authorities. In the UK, it's the Advertising Standards Authority (ASA), which handles complaints post-publication under the CAP Code (Committee of Advertising Practice).

This means the "check" most marketers picture, a regulator reviewing copy before print, mostly doesn't exist for everyday claims. The real gatekeeper is the strength of your own file.

Three claim types, three failure patterns

"Clinically proven."
This phrase implies a specific standard: controlled trials, adequate sample size, statistically significant results, on the actual finished product (not just one ingredient in isolation). A classic failure mode is testing an active ingredient in a lab concentration far higher than what's in the retail formula, then marketing the retail product as "clinically proven." L'Oréal faced FTC scrutiny in 2014 over anti-aging claims (including "clinically proven") for brands like Lancôme and L'Oréal Paris, where the agency argued the science didn't support the marketing language used.

"Natural." This word has no single legal definition in the US or EU for most product categories, which paradoxically makes it more litigated, not less. Class-action lawsuits (private lawsuits brought by a group of consumers) have repeatedly targeted "all natural" claims on products containing synthetic preservatives or processed ingredients. In the EU, "natural" claims intersect with strict rules under the Regulation on Nutrition and Health Claims (EC 1924/2006) for foods, where only pre-approved health claims from the EFSA register (European Food Safety Authority) can be used.

"% more effective." Comparative claims are a magnet for competitor challenges, not regulators. If Unilever claims a detergent is "50% more stain-removing than the leading brand," Procter & Gamble doesn't need to wait for the FTC. It can go straight to the National Advertising Division (NAD), a self-regulatory body run by the BBB National Programs in the US, or sue directly under the Lanham Act (which covers false advertising between competitors). In the EU, comparative advertising is regulated under Directive 2006/114/EC, which requires comparisons to be objective, verifiable and not misleading.

Who actually pulls the claim

Three distinct actors do the pulling, and they move at different speeds:

  • Regulators (FTC, EU national consumer protection authorities, UK's ASA, Competition and Markets Authority): slower, but with real penalty power. The FTC can seek monetary redress and consent orders; EU authorities can levy fines that, under the 2020 "Omnibus Directive" (EU 2019/2161), can reachreachThe number of unique people exposed to your message in a given period. Unlike impressions, reach counts each person once, no matter how often they see it.View full definition → up to 4% of the trader's annual turnover in the relevant member states for widespread infringements.
  • Competitors: fastest, often within weeks of launch, via NAD challenges (US) or direct litigation. NAD decisions aren't legally binding but carry heavy industry weight; refusal to comply gets referred to the FTC.
  • Watchdogs and NGOs: reputational pressure, not legal power, but they shape media cycles and can trigger regulator attention. Examples include Truth in Advertising (TINA.org) in the US and BEUC (The European Consumer Organisation) at EU level.

This is why a claim can survive legal review internally and still get pulled: legal reviewed regulatory risk, but nobody modeled the competitor with a motivated legal team and a rival product losing shelf share.

What a substantiation file actually needs

"Substantiation" is the evidence file that must exist before you make a claim, not evidence you go find once challenged. Regulators and NAD explicitly ask: what proof did you have at the time of publication?

A defensible file typically includes:

1. Underlying study design: sample size, control groups, statistical significance, tested on the actual marketed formula/dose, not a proxy.

2. Claim-to-evidence mapping: the exact wording used in ads must match what the study measured. "Reduces wrinkles" and "reduces the appearance of wrinkles" are legally different claims requiring different evidence.

3. Comparative baseline documentation: if claiming "% more" than a competitor, you need the competitor's actual current formulation, tested head-to-head, not last year's version or marketing claims.

4. Category-specific compliance sign-off: for food and health claims in the EU, verification against the EFSA-approved claims register; for cosmetics, compliance with the EU Cosmetic Products Regulation (EC 1223/2009), which explicitly bans claims implying medicinal effects.

5. Version control and expiry: substantiation ages. A "natural" claim tied to a formula that later changes suppliers or adds a preservative needs re-verification.

A useful framing: build the file as if a competitor's outside counsel will read it in six months, because that is a realistic scenario, not a hypothetical one.

Knowledge check

1. Why does the Kellogg's Rice Krispies example illustrate the typical FMCG claims pattern rather than an unusual failure?

2. What is the core structural reason FMCG brands can ship claims that later fail to hold up, despite having legal departments?

3. A marketer assumes that because a claim appeared in print, it must have passed some official regulatory review beforehand. What is the flaw in this assumption, based on the ex-post enforcement model?

MULTIPLE CHOICE

4. Select ALL correct answers about how regulatory enforcement of FMCG advertising claims works in the US, EU, and UK.

Select all the correct answers.

MULTIPLE CHOICE

5. Select ALL correct answers about why a phrase like 'clinically proven' carries specific risk for FMCG marketers.

Select all the correct answers.

The pre-launch checklist that actually matters

Since there's no regulator pre-clearance, the practical pre-launch check is internal. A workable checklist for marketing and legal teams jointly:

  • Does the claim wording exactly match what the underlying study tested?
  • Is the tested product identical to the SKU (stock keeping unit, the specific retail product) that will ship?
  • For comparative claims, is the comparator current and independently verifiable?
  • For "natural," "clean," or "clinically proven," does the specific market (US vs. EU vs. UK) have a distinct legal threshold you're meeting?
  • Is there a monitoring plan for when the formula, supplier, or claim wording changes post-launch?
  • Has someone modeled the "motivated competitor" scenario, not just the "regulator audit" scenario?

This last point separates mature FMCG marketing organizations from reactive ones. The FTC's guidance on health claims substantiation is a genuinely useful public resource for building this discipline, even for teams operating primarily in Europe, since the underlying evidentiary logic (competent and reliable scientific evidence) is echoed in EU frameworks.

🎬 [VIDEO: "How the FTC Regulates Advertising" - https://www.youtube.com/results?search_query=how+the+ftc+regulates+advertising - search for FTC or law-school explainer videos covering Section 5 enforcement and substantiation standards, useful for a plain-language walkthrough of the ex-post enforcement model]

Key Takeaways

  • FMCG advertising claims are almost never pre-cleared by regulators; the system is ex-post enforcement, so the real safeguard is the strength of your substantiation file, not a government stamp of approval.
  • "Clinically proven," "natural" and comparative "% more" claims each fail in distinct ways: mismatched test conditions, undefined legal terms, and outdated or unverifiable comparators, respectively.
  • Competitors (via bodies like the NAD in the US) often move faster than regulators to challenge claims, because they have direct commercial motive and legal standing under laws like the Lanham Act.
  • A defensible substantiation file must mapmapUsing software to automate repetitive marketing tasks and campaigns, enabling personalisation at scale across channels like email, web, and social.View full definition → exact claim wording to exact study results on the exact shipped formula, and must be built and dated before launch, not assembled reactively after a challenge.
  • EU and US frameworks diverge in detail (EFSA-approved health claims vs. FTC case-by-case substantiation) but share the same core test: competent, reliable evidence held at the time the claim was made.

Next

Marketing to kids without losing the aisle they walk down